Tenders
Cardiovascular drug tenders in Portugal
Cardiovascular drug tenders in Portugal: 4,558 listed on GranTender since 2024. The median awarded contract value is about €240,000 (23 contracts with a stated value). Buyers with the most tenders: Unidade Local de Saúde de Santa Maria, E. P. E. (233), Unidade Local de Saúde do Alto Alentejo, E. P. E. (227) and Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E (195); suppliers with the most contract awards: Generis – Farmaceutica, S.A. (373), Hikma Farmacêutica (Portugal) Sa. (244) and Fresenius Kabi Pharma Portugal (231). Sources: Portal BASE and TED. In 2025 the median contract value was €3,900; 4% of contracts drew a single bid (11.3 bids on average). Data as of 18 November 2026; updated daily.
- Tenders
- 4,558
- Open tenders
- 0
- Awards
- 4,535
- Awarded value awarded
- €17,157,217
- Awarded value contract
- €564,026,539
- Median contract value contract
- ≈ €3,900
- Median contract value awarded
- ≈ €240,000
- Average bids per contract
- 12.5
- Tenders in 2025
- 1,741 +32% on 2024
Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.
Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.
Open tenders
No records yet.
Latest tenders
Top buyers
- Unidade Local de Saúde de Santa Maria, E. P. E.233
- Unidade Local de Saúde do Alto Alentejo, E. P. E.227
- Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E195
- Unidade Local de Saúde do Alto Minho, EPE (ULSAM)178
- Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E.177
- Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.176
- Unidade Local de Saúde de Santo António, E. P. E.168
- Unidade Local de Saúde do Algarve, E.P.E161
- Unidade Local de Saúde da Guarda, E.P.E156
- Unidade Local de Saúde da Região de Leiria, E. P. E.149
Top winners
- Generis – Farmaceutica, S.A.373
- Hikma Farmacêutica (Portugal) Sa.244
- Fresenius Kabi Pharma Portugal231
- Teva Pharma - Produtos Farmaceuticos,lda187
- MYLAN, Lda.176
- Novartis Farma-Prod.farmacêuticos,sa.153
- Sandoz Farmacêutica, Lda.148
- Labesfal-Lab. Almiro, Sa.146
- Overpharma - Produtos Medicos e Farm.121
- Baxter Medico – Farmaceutica120
Competition and prices
In 2025, half of the contracts were worth between €820 and €23,000, with a median of €3,900 (1,594 contracts with a stated contract value). Contracts drew 11.3 bids on average (median 10) and 4% drew a single bid — based on 544 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 26% and the share of single-bid contracts rose from 2% to 4%. The usual procedures: open procedure (54%), restricted procedure (46%) — of 46 tenders with a stated procedure.
The most contracts went to Generis – Farmaceutica, S.A. (373), Hikma Farmacêutica (Portugal) Sa. (244) and Fresenius Kabi Pharma Portugal (231) — together 19% of all contracts.
| Year | Contracts | Median value | Middle half of values | Bids on average | Single bid |
|---|---|---|---|---|---|
| 2024 | 1,365 | €3,100 (contract value) | €730 – €13,000 | 15.6 | 2% (602) |
| 2025 | 1,672 | €3,900 (contract value) | €820 – €23,000 | 11.3 | 4% (544) |
| 2026 (so far) | 1,443 | €4,900 (contract value) | €920 – €26,000 | 8.9 | 1% (445) |
| All years | 4,535 | €3,900 (contract value) | €820 – €19,000 | 12.5 | 2% (1,624) |
Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.
Where you have a chance
Since 1 November 2024, 3% of the 1,000 contracts with a known number of bids had a single bid; the median was 7 bids. The number of bids is known for 1,000 of the 3,456 contracts from procedures with competition.
In the last 12 months, 0 companies won their first contract in our records here — 0% of the 1,375 contracts (our records start on 1 January 2024).
Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.
Main CPV divisions
CPV codes of this topic
A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.
Cardiovascular and anticoagulant drugs in neighbouring countries
Today, 1 tender in the same niche is open in neighbouring countries.
- Spain — 1 open today · how to bid in Spain
Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.
Expected soon3
| Expected | Buyer | What | Why we expect it | Confidence |
|---|---|---|---|---|
| Dec 2026 – Feb 2027 | Unidade Local de Saúde de Lisboa Ocidental, E. P. E. | Cardiovascular and anticoagulant drugs | The buyer has published cardiovascular drug tenders every year in January since 2025. | medium |
| Jan – Mar 2027 | Unidade Local de Saúde da Guarda, E.P.E | Cardiovascular and anticoagulant drugs | The buyer has published cardiovascular drug tenders every year in February since 2025. | medium |
| Jan – Mar 2027 | Unidade Local de Saúde de São José, E. P. E. | Cardiovascular and anticoagulant drugs | The buyer has published cardiovascular drug tenders every year in February since 2025. | medium |
Forecast from public data, not an announcement. Methodology.
Market reports
Cardiovascular and anticoagulant drugs by city
Cardiovascular and anticoagulant drugs in other countries
Cardiovascular and anticoagulant drugs across Europe
Topics in Health, medical equipment and medicines
Questions and answers
- Where can I find cardiovascular drug tenders in Portugal?
- GranTender lists them in one place, from Portal BASE and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
- Who wins the most cardiovascular drug tenders in Portugal?
- By number of contracts won: Generis – Farmaceutica, S.A. (373), Hikma Farmacêutica (Portugal) Sa. (244), Fresenius Kabi Pharma Portugal (231).
- Which buyers publish the most cardiovascular drug tenders in Portugal?
- By number of tenders: Unidade Local de Saúde de Santa Maria, E. P. E. (233), Unidade Local de Saúde do Alto Alentejo, E. P. E. (227), Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E (195).
- Which CPV codes belong to “Cardiovascular and anticoagulant drugs”?
- 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system; plus tenders without a usable CPV code whose title names the topic.
- How many bids do cardiovascular drug tenders in Portugal receive on average?
- In 2025, contracts drew 11.3 bids on average (median 10) and 4% drew a single bid — based on 544 contracts with a known number of bids.
- How much are contracts for cardiovascular drug tenders in Portugal worth?
- In 2025, half of the contracts were worth between €820 and €23,000, with a median of €3,900 (1,594 contracts with a stated contract value). Compared with 2024, in 2025 the median value rose 26% and the share of single-bid contracts rose from 2% to 4%.
- Which procedures are used for cardiovascular drug tenders in Portugal?
- The usual procedures: open procedure (54%), restricted procedure (46%) — of 46 tenders with a stated procedure.
CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.